A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...

The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...

Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price increased by equities researchers at Barclays from ...

Pediatrician Dr. Mario Yanakiev has warned that a second flu wave is expected to follow the peak of the first.

The Ministry of Public Health yesterday confirmed the discovery of a new coronavirus, HKU5-CoV-2, by a laboratory in China but said no human infections have been recorded as yet.Dr Opas Karnkawinpong, ...

Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC ...

Last winter, one Brisbane mother saw two of her children admitted to different hospitals as beds ran out. This year, ...

The World Health Organization has warned that its largest global laboratory network is on the brink of collapse unless new funding is secured to replace the support lost after President Donald Trump’s ...